Literature DB >> 24263160

Metformin as a Rare Cause of Drug-Induced Liver Injury, a Case Report and Literature Review.

Lin Zheng1.   

Abstract

Metformin is an oral hypoglycemic agent that is commonly used in the treatment of type 2 diabetes mellitus. Although metformin-associated gastrointestinal upset and metabolic acidosis is widely recognized side effect of this drug, metformin-induced liver injury has been rarely reported in the literature. In most cases reported, metformin-induced liver injury was associated with concomitant intake of other hepatotoxic drugs. Here, we report a case of a 70-year-old white woman who suffered metformin-induced liver injury 5 weeks after starting on this medication, and she was not on any other hepatotoxic agent. With increasing prescription of metformin, this case deserves particular attention for this rare but important side effect.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 24263160     DOI: 10.1097/MJT.0000000000000007

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  5 in total

1.  Differential effects of metformin-mediated BSEP repression on pravastatin and bile acid pharmacokinetics in humans: A randomized controlled trial.

Authors:  Melissa Metry; Samuel A Krug; Vijaya Kumari Karra; Maureen A Kane; Jeffrey C Fink; Yan Shu; Hongbing Wang; James E Polli
Journal:  Clin Transl Sci       Date:  2022-08-07       Impact factor: 4.438

2.  Liver Label Retaining Cancer Cells Are Relatively Resistant to the Reported Anti-Cancer Stem Cell Drug Metformin.

Authors:  Hong-Wu Xin; Chenwi M Ambe; Tyler C Miller; Jin-Qiu Chen; Gordon W Wiegand; Andrew J Anderson; Satyajit Ray; John E Mullinax; Danielle M Hari; Tomotake Koizumi; Jessica D Godbout; Paul K Goldsmith; Alexander Stojadinovic; Udo Rudloff; Snorri S Thorgeirsson; Itzhak Avital
Journal:  J Cancer       Date:  2016-06-06       Impact factor: 4.207

3.  Diabetes mellitus increases the risk of hepatocellular carcinoma in treatment-naïve chronic hepatitis C patients in China.

Authors:  Xu Li; Hongqin Xu; Yang Gao; Meng Pan; Le Wang; Pujun Gao
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

4.  Literature review of the clinical characteristics of metformin-induced hepatotoxicity.

Authors:  Chunjiang Wang; Hongyi Deng; Yunfei Xu; Ying Liu
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

5.  Metformin toxicity: A meta-summary of case reports.

Authors:  Deven Juneja; Prashant Nasa; Ravi Jain
Journal:  World J Diabetes       Date:  2022-08-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.